3 results for "fda"
FDA excludes semaglutide and tirzepatide from compounding, reshaping access to obesity drugs. Here's what it means for your health.
FDA cuts trial lag with real-time data from AstraZeneca and Amgen. $6.4B drug patent extended until 2031. Here's your protocol to navigate faster approvals, AI-
A $10 telehealth visit for Addyi: drugmakers fund consults to boost scripts. 1 in 4 women may be affected.
